© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
In every issue, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.
Also Available On:
ISSUU
The 2017 POZ 100 celebrates the contributions of women in the fight against HIV.
The 2017 POZ 100 list celebrates the contributions of women in the fight against HIV.
I am not a woman, but I do feel energized whenever I hear songs of empowerment for women.
Immigration Equality advocates on behalf of both LGBT immigrants and all immigrants living with HIV.
HIV/AIDS groups offer emergency relief to hurricane-battered regions.
Our October cover story on Puerto Rico was published just days before Maria made landfall.
There’s effectively no risk of transmission from an HIV-positive partner to an HIV-negative partner when the virus is fully suppressed.
Visual AIDS commissions seven videos of Black narratives within the epidemic.
January 1, 2018, will mark a new dawn for HIV crime laws in California, thanks to a law signed by Governor Jerry Brown.
Love is the message in this short film about HIV, disclosure and dating.
HIV researcher David Alain Wohl, MD, urges AIDS activists to be a vanguard against indifference, overreach and shortsightedness.
Writer Anna Forbes responds to an open letter by HIV researcher David Alain Wohl, MD, that urges AIDS activists to do more.
The social media buzz on the 21st United States Conference on AIDS.
The results of our POZ Survey on self-care are in.
Leaders at Kaiser Permanente Northern California want to broaden the definition of “PrEP failure."
A recent study tested the long-acting injectable antiretrovirals cabotegravir and Edurant (rilpivirine) given every four or eight weeks.
Scientists are investigating how the apparent size of an individual’s reservoir may help predict the length of viral remission.
Youths on HIV meds may episodically develop a significant risk of transmitting the virus.
The CDC estimates that of the 1.1 million U.S. residents living with HIV in 2014, 49 percent had an undetectable viral load.
Even when HIV is fully suppressed, the virus is associated with as much as double the risk of cardiovascular disease (CVD).
Among people with HIV who don’t have hepatitis C virus, various factors raise the risk of liver fibrosis and fatty liver disease.
Curing HCV in those coinfected with HIV provides the greatest chance to reduce the risk of death among those who have advanced fibrosis.
Jesús Aguais is the founder and executive director of Aid for AIDS.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.